cAMP-responsive element-binding protein regulates vascular endothelial growth factor expression: implication in human prostate cancer bone metastasis

D Wu, HE Zhau, WC Huang, S Iqbal, FK Habib… - Oncogene, 2007 - nature.com
D Wu, HE Zhau, WC Huang, S Iqbal, FK Habib, O Sartor, L Cvitanovic, FF Marshall, Z Xu…
Oncogene, 2007nature.com
Aberrant expression of vascular endothelial growth factor (VEGF) is associated with human
prostate cancer (PCa) metastasis and poor clinical outcome. We found that both
phosphorylation of cyclic AMP-responsive element-binding protein (CREB) and VEGF levels
were significantly elevated in patient bone metastatic PCa specimens. A PCa ARCaP
progression model demonstrating epithelial-to-mesenchymal transition exhibited increased
CREB phosphorylation and VEGF expression as ARCaP cells became progressively more …
Abstract
Aberrant expression of vascular endothelial growth factor (VEGF) is associated with human prostate cancer (PCa) metastasis and poor clinical outcome. We found that both phosphorylation of cyclic AMP-responsive element-binding protein (CREB) and VEGF levels were significantly elevated in patient bone metastatic PCa specimens. A PCa ARCaP progression model demonstrating epithelial-to-mesenchymal transition exhibited increased CREB phosphorylation and VEGF expression as ARCaP cells became progressively more mesenchymal and bone-metastatic. Activation of CREB induced, whereas inhibition of CREB blocked, VEGF expression in ARCaP cells. CREB may regulate VEGF transcription via a hypoxia-inducible factor-dependent mechanism in normoxic conditions. Activation of CREB signaling is involved in the coordinated regulation of VEGF and may pre-dispose to PCa bone metastasis.
nature.com